U.S. Global Investors (USGI)’s Gilead Sciences GILD Stock Holding History

U.S. Global Investors (USGI)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,397	Closed	-$771K	–	168
2016 Q1	$771K	Sell	8,397 -12,403	-60%	-$1.12M	0.41%	84
2015 Q4	$2.1M	Buy	20,800 +10,600	+104%	+$1.1M	1.1%	21
2015 Q3	$1M	Buy	10,200 +2,200	+28%	+$244K	0.53%	62
2015 Q2	$937K	Buy	8,000 +2,000	+33%	+$219K	0.36%	75
2015 Q1	$589K	Sell	6,000 -6,000	-50%	-$609K	0.16%	130
2014 Q4	$1.13M	Sell	12,000 -1,000	-8%	-$103K	0.3%	76
2014 Q3	$1.38M	Buy	13,000 +3,000	+30%	+$294K	0.39%	83
2014 Q2	$829K	Buy	+10,000	New	+$778K	0.18%	112

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

U.S. Global Investors (USGI)'s GILD Position: Q2 2016 in Review

U.S. Global Investors (USGI) sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 8,397 shares — an estimated $771K sold.

U.S. Global Investors (USGI) first reported a position in GILD in Q2 2014 and held it in 8 quarters. The position peaked at $2.1M in Q4 2015. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

U.S. Global Investors (USGI) reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
U.S. Global Investors (USGI) sold 8,397 Gilead Sciences shares in Q2 2016, an estimated $771K.
U.S. Global Investors (USGI) first reported a position in Gilead Sciences in Q2 2014 and held it in 8 quarters.
U.S. Global Investors (USGI)'s Gilead Sciences position peaked at $2.1M in Q4 2015.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on U.S. Global Investors (USGI)'s 13F filing for Q2 2016, filed 10 Aug 2016.